SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lambert, M
Right arrow Articles by Duriez, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lambert, M
Right arrow Articles by Duriez, P
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies

M Lambert

Department of Internal Medicine, Huriez Hospital, University Hospital, University of Lille 2, Lille, France; Research Department on Lipoproteins and Atherosclerosis, INSERM U325. Pasteur Institute and University of Lille 2, Lille, France

A Boullier

Research Department on Lipoproteins and Atherosclerosis, INSERM U325. Pasteur Institute and University of Lille 2, Lille, France

E Hachulla

Department of Internal Medicine, Huriez Hospital, University Hospital, University of Lille 2, Lille, France

J-C Fruchart

E Teissier

Research Department on Lipoproteins and Atherosclerosis, INSERM U325. Pasteur Institute and University of Lille 2, Lille, France

P-Y Hatron

Department of Internal Medicine, Huriez Hospital, University Hospital, University of Lille 2, Lille, France

P Duriez

Déines et l'Athérosclérose, INSERM U325, Institut Pasteur, 1 rue du Professeur Calmette, BP 245, 59019, Lille, France. Tel: (/33) 3 20 87 78 86; Fax: (/33) 3 20 87 73 60; Patrick.Duriez{at}pastcur-lille.fr

It has been reported that paraoxonase 1 (PON1) activity inhibits low-density lipoprotein (LDL) oxidation and modulates the risk of coronary heart disease. This study shows that autoantibodies (IgG) directed against modified LDL were increased in 71 patients positive for anticardiolipin antibodies. In a representative subgroup of these patients (n ‘ 36) PON1 activity was dramatically decreased and the prevalence of the RR genotype of this enzyme tended to be increased in patients who had developed arterial thrombosis. This study suggests that PON1 abnormalities play a role in the antiphospholipid syndrome.

Key Words: paraoxonase 1 • anticardiolipin antibodies • oxidized-LDL

Lupus, Vol. 9, No. 4, 299-300 (2000)
DOI: 10.1191/096120300680198980


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
M. Charakida, C. Besler, J. R. Batuca, S. Sangle, S. Marques, M. Sousa, G. Wang, D. Tousoulis, J. Delgado Alves, S. P. Loukogeorgakis, et al.
Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome
JAMA, September 16, 2009; 302(11): 1210 - 1217.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
E Matsuura and L. Lopez
Autoimmune-mediated atherothrombosis
Lupus, October 1, 2008; 17(10): 879 - 888.
[Abstract] [PDF]


Home page
LupusHome page
M McMahon, J Grossman, W Chen, and B H Hahn
Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus
Lupus, November 1, 2006; 15(11_suppl): 59 - 69.
[Abstract] [PDF]


Home page
LupusHome page
E Matsuura, K Kobayashi, B. Hurley, and L. Lopez
Atherogenic Oxidized Low-Density Lipoprotein/{beta}2-Glycoprotein I (oxLDL/{beta}2GPI) Complexes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Lupus, July 1, 2006; 15(7): 478 - 483.
[Abstract] [PDF]


Home page
LupusHome page
J D. Alves, E L Radway-Bright, S Lee, B Grima, J Hothersall, C T Ravirajan, and D A Isenberg
Antiphospholipid antibodies are induced by in vitro fertilization and correlate with paraoxonase activity and total antioxidant capacity of plasma in infertile women
Lupus, May 1, 2005; 14(5): 373 - 380.
[Abstract] [PDF]



Advertisement